(firstQuint)Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes Mellitus.

 To compare the total pharmacodynamic response of URAL and insulin lispro.

 To compare the total pharmacokinetic exposure between URAL and insulin lispro.

 To assess the safety and tolerability of URAL and insulin lispro.

.

 Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes Mellitus@highlight

To compare the early pharmacokinetic exposure of URAL and insulin lispro (ILisp).

